Cosmos Health (COSM) Net Margin (2014 - 2026)
Cosmos Health's (COSM) quarterly Net Margin came in at 32.06% in Q2 2026, down 1288.0% on a YoY basis from 2.7% in Q2 2025, and down 104.86% quarter-over-quarter from 15.65% in Q1 2026.
Powered by 
Analysis
Cosmos Health (COSM) Net Margin (2014 - 2026) Analysis & Trends
Cosmos Health (COSM) has reported Net Margin for 12 consecutive years, with 32.06% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Net Margin fell 1288.0% year-over-year to 32.06%; the trailing twelve-month figure through Jun 2026 stood at 27.63% (up 1152.0% YoY), and the FY2025 full-year result was 23.19%, up 1793.0% from the prior year.
- Net Margin eased to 32.06% in Q2 2026 per COSM's latest filing, from 15.65% in the prior quarter.
- Across five years, Net Margin topped out at 124.92% in Q4 2022 and bottomed at 138.2% in Q2 2022.
- Historically, Net Margin has averaged 30.13% across 5 years, with a median of 22.93% in 2024.
- The sharpest annual moves came in 2022 and 2023: Net Margin jumped 13402 bps in 2022, then plunged 25736 bps in 2023.
- Over 5 years, Net Margin stood at 124.92% in 2022, then slumped by 206 bps to 132.44% in 2023, then soared by 49 bps to 67.09% in 2024, then jumped by 54 bps to 31.09% in 2025, then retreated by 3 bps to 32.06% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 32.06%, 15.65%, and 31.09% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.33 Bn | 38.68 Bn | 2.15 Bn | -13.91% |
| 2 | Viatris | 19.05 Bn | 18.16 Bn | 1.46 Bn | -3.16% |
| 3 | Dr Reddys Laboratories | 9.76 Bn | 9.58 Bn | 396.53 Mn | 5.50% |
| 4 | Amneal Pharmaceuticals | 5.38 Bn | 5.25 Bn | 334.51 Mn | 8.74% |
| 5 | Bausch Health Companies | 2.27 Bn | 436.38 Mn | 2.10 Bn | 9.12% |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn | -121.81% |
| 7 | Ani Pharmaceuticals | 1.51 Bn | 1.15 Bn | 165.89 Mn | 9.28% |
| 8 | Amphastar Pharmaceuticals | 1.03 Bn | 737.26 Mn | 93.47 Mn | 16.50% |
| 9 | Fennec Pharmaceuticals | 393.12 Mn | 351.87 Mn | 17.15 Mn | 11.04% |
| 10 | Cosmos Health | 15.08 Mn | 12.63 Mn | 1.51 Mn | -32.06% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -32.06% |
| Mar 31, 2026 | -15.65% |
| Dec 31, 2025 | -31.09% |
| Sep 30, 2025 | -31.28% |
| Jun 30, 2025 | -19.18% |
| Mar 31, 2025 | -5.97% |
| Dec 31, 2024 | -67.09% |
| Sep 30, 2024 | -67.50% |
| Jun 30, 2024 | -19.62% |
| Mar 31, 2024 | -12.80% |
| Dec 31, 2023 | -132.44% |
| Sep 30, 2023 | -26.23% |
| Jun 30, 2023 | -7.94% |
| Mar 31, 2023 | -3.72% |
| Dec 31, 2022 | 124.92% |
| Sep 30, 2022 | -13.27% |
| Jun 30, 2022 | -138.20% |
| Mar 31, 2022 | -43.23% |
| Dec 31, 2021 | -9.10% |
| Sep 30, 2021 | -14.24% |